Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial.

Ulagamadesan VenkatesanEmil WolskBrian ClaggettRafael DiazKenneth DicksteinSibylle HessLars KoberAldo P MaggioniJohn J V McMurrayJeffrey L ProbstfieldMatthew C RiddleJean-Claude TardifMarc A Pfeffer

Published in: Diabetes, obesity & metabolism (2022)

Keyphrases

acute coronary syndrome
phase iii
percutaneous coronary intervention
study protocol
antiplatelet therapy
phase ii
clinical trial
ejection fraction
amino acid
randomized controlled trial
open label